Pipeline Moves: Novartis completes ulcerative colitis trial, advancement prospects rise
The Clinical Trials Arena team also reviews assets in oncology, paediatric hormone deficiency, diabetic pain and ophthalmology.
Just announced: upcoming HIV late-stage clinical trials
Running low on comparators: navigating drug shortages in oncology clinical trials
Redx Pharma previews development plans for idiopathic pulmonary fibrosis and fibrostenotic Crohn’s disease
UCI Health and UCI Alpha Clinic launch muscle atrophy therapy trial
NETRIS Pharma begins subject dosing in solid tumour therapy trial
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreVaxxinity’s Phase III Covid-19 booster trial meets endpoints
In the trial, the UB-612 vaccine was generally well tolerated, without any serious adverse events occurring.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% drop in new job postings related to social responsibility in Q3 2022 compared…
Intravacc enrols first subject in intranasal Covid-19 booster trial
Anticoagulant unbeneficial for Covid-19 University of Cambridge trial finds
Leading clinical trials companies in the artificial intelligence theme
Robotics innovation: Leading companies in microneedles for transdermal drug delivery